Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-19-016535
Filing Date
2019-09-11
Accepted
2019-09-11 17:21:41
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 forms3.htm S-3 775269
2 EXHIBIT 1.2 ex1_2.htm EX-1.2 211943
3 EXHIBIT 4.3 ex4_3.htm EX-4.3 319902
4 EXHIBIT 5.1 ex5_1.htm EX-5.1 36805
5 EXHIBIT 5.2 ex5_2.htm EX-5.2 17705
6 EXHIBIT 5.3 ex5_3.htm EX-5.3 17483
7 EXHIBIT 23.1 ex23_1.htm EX-23.1 1676
8 image00001.jpg GRAPHIC 3214
9 image00002.jpg GRAPHIC 2518
10 image00003.jpg GRAPHIC 3223
11 image00004.jpg GRAPHIC 2632
12 image00005.jpg GRAPHIC 3154
13 image00006.jpg GRAPHIC 2405
  Complete submission text file 0001140361-19-016535.txt   1406160
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-233716 | Film No.: 191089046
SIC: 2834 Pharmaceutical Preparations